HCA Holdings Inc. buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€210.20
Target price
30.10.24
€265.10
Performance (%)
57.99%
End price
31.10.24
€332.10
Summary
This prediction ended on 31.10.24 with a price of €332.10. With a performance of 57.99% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has a follow-up prediction for HCA Holdings Inc. where he still thinks HCA Holdings Inc. is a Buy. Dividends of €2.37 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| HCA Holdings Inc. | -4.535% | -4.535% | 46.975% |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $329.00 to $281.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
In the thread Trading HCA Holdings Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten